HQL Stock - Tekla Life Sciences Investors
Unlock GoAI Insights for HQL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $86.39M | $86.69M | $39.39M | $31.86M | $45.02M |
| Gross Profit | $86.39M | $86.69M | $18.28M | $26.31M | $38.95M |
| Gross Margin | 100.0% | 100.0% | 46.4% | 82.6% | 86.5% |
| Operating Income | $85.59M | $85.30M | $-5,244,047 | $-104,603,100 | $64.53M |
| Net Income | $85.59M | $85.30M | $22.35M | $-104,603,100 | $64.53M |
| Net Margin | 99.1% | 98.4% | 56.8% | -328.3% | 143.3% |
| EPS | $0.00 | $3.04 | $0.79 | $-4.07 | $2.66 |
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.
Visit WebsiteEarnings History & Surprises
HQLEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2025 | Jun 24, 2025 | — | $-1.64 | — | — |
Q4 2024 | Dec 9, 2024 | — | $1.22 | — | — |
Q3 2024 | Aug 6, 2024 | — | $1.84 | — | — |
Q4 2023 | Dec 11, 2023 | — | $-0.43 | — | — |
Q1 2023 | Mar 31, 2023 | — | $1.29 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-1.10 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-3.03 | — | — |
Q3 2021 | Sep 30, 2021 | — | $1.34 | — | — |
Q1 2021 | Mar 31, 2021 | — | $1.30 | — | — |
Q3 2020 | Sep 30, 2020 | — | $3.91 | — | — |
Q1 2020 | Mar 31, 2020 | — | $1.29 | — | — |
Q3 2019 | Sep 30, 2019 | — | $-1.33 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-1.72 | — | — |
Q3 2018 | Sep 30, 2018 | — | $2.12 | — | — |
Q1 2018 | Mar 31, 2018 | — | $-0.90 | — | — |
Q3 2017 | Sep 30, 2017 | — | $1.94 | — | — |
Q1 2017 | Mar 31, 2017 | — | $1.27 | — | — |
Q3 2016 | Sep 30, 2016 | — | $2.77 | — | — |
Q1 2016 | Mar 31, 2016 | — | $-3.44 | — | — |
Q3 2015 | Sep 30, 2015 | — | $-2.57 | — | — |
Latest News
Frequently Asked Questions about HQL
What is HQL's current stock price?
What is the analyst price target for HQL?
What sector is Tekla Life Sciences Investors in?
What is HQL's market cap?
Does HQL pay dividends?
Similar Stocks
Financial Services SectorExplore stocks similar to HQL for comparison